Laboratoires Euromedis specializes in the design, manufacturing and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The products include gloves (No. 1 in France in disposable medical gloves), surgical items (sensors, pockets, scalpels, etc.), hygiene and protection equipment (white-coats, masks, shoes, etc.), parenteral approaches (needles, syringes, transfusion equipment, etc.), diagnostic products, etc.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	14.16M 16.53M 13.25M 12.13M 22.76M 1.58B 23.07M 157M 61.05M 795M 62.08M 60.73M 2.63B	P/E 2024	-2.05x	P/E 2025	-84.9x
Enterprise Value	3.6M 4.2M 3.37M 3.08M 5.78M 402M 5.86M 39.77M 15.51M 202M 15.77M 15.43M 668M	EV / Sales 2024	0.57x	EV / Sales 2025	0.01x
Free-Float	34.87%	Yield 2024 *	-	Yield 2025	-

Apr. 29	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
25-10-31	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-05-04	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-10-24	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
23-10-31	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-04-27	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-09-30	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-04-29	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2021	CI
21-09-30	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2021	CI
21-07-08	Euromedis Groupe : Malaysia rubber glove body pleads for go-ahead to restart factories	RE
21-04-26	Global markets live: Philips, Crédit Suisse, Nestlé...
21-04-23	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2020	CI
20-09-23	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2020	CI

25-10-31	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER SEMESTRIEL 2025	PU
25-10-31	Laboratoires Euromedis : Euromedis - Communiqué semestriel 2025	PU
24-12-10	LABORATOIRES EUROMEDIS : Ajustement du contrat de liquidité	PU
24-04-26	Laboratoires Euromedis : Euromedis - Communiqué résultat 2023	PU
22-09-29	EUROMEDIS : Rapport Financier semestriel 2022	PU

Jun. 19	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré
May. 06	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER ANNUEL 2025
May. 06	LABORATOIRES EUROMEDIS : Fin du contrat de liquidité
Apr. 24	Laboratoires Euromedis : Communiqué résultat 2025
Apr. 24	Laboratoires Euromedis : Résultats 2025 (7. Laboratoires Euromedis Communiqu e de presse r sultat 2025 v23.04.26)

Director	Title	Age	Since
Mathieu Roturier CHM	Chairman	49	2019-11-25
Joseph Asselin BRD	Director/Board Member	52	2017-03-07
Marion Tramier BRD	Director/Board Member	40	2017-03-07

EUROMEDIS Stock Swiss Exchange

Stocks

OXEUMD

FR0000075343

Medical Equipment, Supplies & Distribution

Valuation: EUROMEDIS

Latest news : EUROMEDIS

Press Releases: EUROMEDIS

News in other languages: EUROMEDIS

Managers and Directors: EUROMEDIS

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EUROMEDIS	-.--%	-.--%	-	-	16.53M
ABBOTT LABORATORIES	+2.19%	+4.84%	-12.03%	+10.95%	202B
MEDTRONIC PLC	+1.14%	+2.28%	+0.69%	+11.56%	119B
CENCORA, INC.	+1.06%	+1.34%	+8.69%	+78.91%	60.69B
HOYA CORPORATION	0.00%	-5.70%	+29.16%	+55.35%	52.38B
BECTON, DICKINSON AND COMPANY	+2.33%	+4.69%	-3.84%	-30.71%	52.3B
DEXCOM, INC.	+2.35%	+2.89%	+12.25%	-11.53%	34.85B
MEDLINE INC.	+5.16%	-4.14%	-	-	30.06B
WEST PHARMACEUTICAL SERVICES, INC.	-0.20%	+1.05%	+42.46%	-10.17%	24.85B
TERUMO CORPORATION	+1.03%	-0.94%	-1.24%	+24.84%	23.84B
Average	+1.51%	+0.28%	+9.52%	+16.15%	66.7B
Weighted average by Cap.	+1.70%	+1.90%	+1.69%	+16.85%

	2024	2025
Net sales	36.41M 42.51M 34.07M 31.19M 58.53M 4.07B 59.3M 403M 157M 2.04B 160M 156M 6.76B	41.06M 47.94M 38.42M 35.17M 66M 4.59B 66.88M 454M 177M 2.3B 180M 176M 7.62B
Net income	-6.11M -7.13M -5.72M -5.23M -9.82M -682M -9.95M -67.52M -26.33M -343M -26.77M -26.19M -1.13B	-132K -154K -123K -113K -212K -14.72M -215K -1.46M -568K -7.39M -578K -565K -24.46M
Net Debt	8.04M 9.38M 7.52M 6.88M 12.92M 898M 13.09M 88.85M 34.65M 451M 35.23M 34.46M 1.49B	-10.57M -12.33M -9.89M -9.05M -16.98M -1.18B -17.21M -117M -45.55M -593M -46.31M -45.3M -1.96B